Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Group 2 Pulmonary Hypertension”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Large-scale testing (Phase 3)Study completedNCT01720524
What this trial is testing

Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn

Who this might be right for
Pulmonary Hypertension, Familial Persistent, of the Newborn
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 59
Testing effectiveness (Phase 2)Study completedNCT01728220
What this trial is testing

Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD

Who this might be right for
Pulmonary HypertensionChronic Obstructive Pulmonary Disease
Bellerophon Pulse Technologies 159
Testing effectiveness (Phase 2)Ended earlyNCT01725256
What this trial is testing

Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Aires Pharmaceuticals, Inc. 29
Not applicableWithdrawnNCT05205265
What this trial is testing

Rivet PVS Therapy in Group 2 PH-HFpEF

Who this might be right for
Heart FailurePulmonary Hypertension
NXT Biomedical
Testing effectiveness (Phase 2)Study completedNCT02279160
What this trial is testing

Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics 61
Testing effectiveness (Phase 2)Looking for participantsNCT07221513
What this trial is testing

Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension

Who this might be right for
HFrEF - Heart Failure With Reduced Ejection FractionHFpEF - Heart Failure With Preserved Ejection FractionGroup 2 Pulmonary Hypertension
Salubris Biotherapeutics Inc 30
Testing effectiveness (Phase 2)Study completedNCT04456998
What this trial is testing

GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Artery Hypertension
GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 86
Testing effectiveness (Phase 2)Study completedNCT05737940
What this trial is testing

AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2

Who this might be right for
Pulmonary Hypertension (World Health Organization Group 2)Heart Failure
AstraZeneca 260
Testing effectiveness (Phase 2)Study completedNCT02664558
What this trial is testing

Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)

Who this might be right for
Pulmonary Arterial Hypertension
Eiger BioPharmaceuticals 61
Early research (Phase 1)Study completedNCT03754660
What this trial is testing

This Study Tests the Safety of Inhaled BAY1237592, How the Drug is Tolerated and How it Effects Patients With High Blood Pressure in the Arteries of the Lungs in the Two Different Disease Groups Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Who this might be right for
Hypertension, Pulmonary
Bayer 38
Post-approval studies (Phase 4)Not Yet RecruitingNCT07147114
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety in Concomitant Administration of Macitentan and Dapagliflozin in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction (HFmrEF and HFpEF) and Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH)

Who this might be right for
Combined Pre- and Post-capillary Pulmonary HypertensionCpcPHHFmrEF+2 more
Gachon University Gil Medical Center 64
Testing effectiveness (Phase 2)WithdrawnNCT04882774
What this trial is testing

Telemonitoring to Treat Group 2 Pulmonary Hypertension

Who this might be right for
Pulmonary Hypertension Due to Left Heart Disease
Mardi Gomberg -Maitland MD, MSc
Testing effectiveness (Phase 2)Study completedNCT01265888
What this trial is testing

Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl.

Who this might be right for
Pulmonary Arterial HypertensionIdiopathic Pulmonary Fibrosis
Geno LLC 31
Not applicableWithdrawnNCT05332873
What this trial is testing

Rivet PVS Therapy in Group 2 PH-HFpEF Canada

Who this might be right for
Heart FailurePulmonary Hypertension
NXT Biomedical
Testing effectiveness (Phase 2)Study completedNCT00414687
What this trial is testing

Aerosolized Randomized Iloprost Study II (AIR - II) Long-Term Safety, Tolerability, and Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary Hypertension

Who this might be right for
Hypertension, Pulmonary
Bayer 63
Large-scale testing (Phase 3)Looking for participantsNCT07288398
What this trial is testing

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

Who this might be right for
Pulmonary Hypertension Associated With HFpEF
Tenax Therapeutics, Inc. 540
Not applicableUnknownNCT05856461
What this trial is testing

Pulmonary Artery Denervation in Patients With Atrial Fibrillation and Group 2 of Pulmonary Hypertension

Who this might be right for
Atrial FibrillationPulmonary Hypertension
Meshalkin Research Institute of Pathology of Circulation 116
Not applicableLooking for participantsNCT06052072
What this trial is testing

Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study)

Who this might be right for
Group 2 Pulmonary HypertensionHeart Failure
Gradient Denervation Technologies 50
Testing effectiveness (Phase 2)Ended earlyNCT03884465
What this trial is testing

Hemodynamic Evaluation of Dose-response and Safety of Dry Powder Inhalation of Treprostinil

Who this might be right for
Pulmonary Arterial Hypertension
Liquidia Technologies, Inc. 15
Testing effectiveness (Phase 2)Ended earlyNCT01725269
What this trial is testing

Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05

Who this might be right for
Pulmonary Arterial Hypertension
Aires Pharmaceuticals, Inc. 17
Load More Results